Is Superbug another health crisis?

The fear of H1N1 has just subsided after hundreds of millions of dollars were spent to stock up the vaccine by fearful nations, particularly those countries that have a lot of money to pay for the drug. The pharmaceutical companies must be very thankful for the monetary windfall for a crisis that was blown out of proportion and is now seen as not worst off than another variation of the common flu